Your browser doesn't support javascript.
loading
Corrigendum to 'Population pharmacokinetics-based recommendations for a single delayed or missed dose of nusinersen': Neuromuscular Disorders 31 (2021) 310-318/doi: 10.1016/j.nmd.2021.02.014.
MacCannell, Drew; Berger, Zdenek; East, Lilly; Mercuri, Eugenio; Kirschner, Janbernd; Muntoni, Francesco; Farrar, Michelle A; Peng, Joanna; Zhou, Jie; Nestorov, Ivan; Farwell, Wildon; Finkel, Richard S.
Afiliação
  • MacCannell D; Biogen, Cambridge, MA, USA.
  • Berger Z; Biogen, Cambridge, MA, USA.
  • East L; Biogen, Cambridge, MA, USA.
  • Mercuri E; Department of Pediatric Neurology, Catholic University, Rome, Italy.
  • Kirschner J; Department of Neuropediatrics, University Hospital Bonn, Bonn, Germany.
  • Muntoni F; Dubowitz Neuromuscular Centre, NIHR Great Ormond Street Hospital Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health & Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Farrar MA; Department of Neurology, Sydney Children's Hospital and School of Women's and Children's Health, UNSW Medicine, Sydney, New South Wales, Australia.
  • Peng J; Nuventra Pharma Sciences, Research Triangle Park, NC, USA.
  • Zhou J; Nuventra Pharma Sciences, Research Triangle Park, NC, USA.
  • Nestorov I; Biogen, Cambridge, MA, USA.
  • Farwell W; Biogen, Cambridge, MA, USA.
  • Finkel RS; Center for Experimental Neurotherapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: richard.finkel@stjude.org.
Neuromuscul Disord ; 32(1): e1, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35144755

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article